Atlas Trials

Invivoscribe, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Invivoscribe, Inc.

RecordFirmDate
Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay (NCT06876571)Invivoscribe, Inc.2025-06-02
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research (NCT06222164)Invivoscribe, Inc.2024-03-30
Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay (NCT06112301)Invivoscribe, Inc.2024-01-02
The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines (NCT04391400)Invivoscribe, Inc.2020-06-01

Track Invivoscribe, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.